Vanguard Capital Management’s Harte-Hanks HHS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1.15M Sell
252,858
-6,178
-2% -$21.1K ﹤0.01% 3522
2026
Q2
$560K Hold
259,036
– – ﹤0.01% 3699
2026
Q1
$588K Buy
+259,036
New +$735K ﹤0.01% 3644

Other funds holding HHS

Vanguard Capital Management's HHS Position: Q3 2026 in Review

Vanguard Capital Management reduced its Harte-Hanks (HHS) stake by 2.4% in Q3 2026, selling an estimated $21.1K and leaving 252,858 shares worth $1.15M. The position accounts for ﹤0.01% of the portfolio, ranked #3522.

Vanguard Capital Management first reported a position in HHS in Q1 2026 and has held it in 3 quarters since. 22 funds tracked by Wall St. Rank hold HHS as of Q3 2026.

  • Vanguard Capital Management held 252,858 shares of Harte-Hanks worth $1.15M as of Q3 2026.
  • Vanguard Capital Management sold 6,178 Harte-Hanks shares in Q3 2026, an estimated $21.1K.
  • Harte-Hanks made up ﹤0.01% of Vanguard Capital Management's portfolio in Q3 2026, its #3522 holding.
  • Vanguard Capital Management first reported a position in Harte-Hanks in Q1 2026 and has held it in 3 quarters since.
  • 22 funds tracked by Wall St. Rank held Harte-Hanks as of Q3 2026.

Based on Vanguard Capital Management's 13F filing for Q3 2026, filed 13 Nov 2026.